LMAT – lemaitre vascular, inc. (US:NASDAQ)
Stock Stats
News
5/9
04:24 pm
lmat
Neutral
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance [Yahoo! Finance]
5/5
09:28 am
lmat
Medium
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
5/4
09:33 am
lmat
Medium
LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/3
11:32 pm
lmat
Medium
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
5/3
05:11 pm
lmat
Medium
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at JMP Securities from $72.00 to $77.00. They now have a "market outperform" rating on the stock.
5/2/2024
04:05 pm
LMAT
11.2%
BEAT
2/27/2024
04:05 pm
LMAT
14.4%
BEAT
11/1/2023
04:05 pm
LMAT
-2.4%
BEAT
8/1/2023
04:05 pm
LMAT
3.0%
BEAT
5/3
04:42 pm
Maintains
Outperform
Outperform
Barrington Research
Low
1.1%
5/3
03:08 pm
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
1.6%
5/3
03:08 pm
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
1.6%
4/26
07:03 am
Upgrades
Hold
Buy
Stifel Nicolaus
Low
2.7%
4/26
07:03 am
Upgrades
Hold
Buy
Stifel Nicolaus
Low
2.7%
5/8
04:52 pm
lmat
Low
Form 4 LEMAITRE VASCULAR INC For: May 06 Filed by: LeMaitre George W
5/8
04:36 pm
lmat
Low
Form 4 LEMAITRE VASCULAR INC For: May 06 Filed by: Roberts David B
5/6
04:44 pm
lmat
Low
Form 144 LEMAITRE VASCULAR INC Filed by: LeMaitre George W
5/6
03:39 pm
lmat
Low
Form 144 LEMAITRE VASCULAR INC Filed by: LeMaitre George W
5/6
01:15 pm
lmat
Low
Form 144 LEMAITRE VASCULAR INC Filed by: Roberts David B
Show more
Top News Gainers
3/23 Form 4 LEMAITRE VASCULAR INC For: Mar 19 Filed by: LeMaitre George W 9.6%
4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%
4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%
7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%
9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%
10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%
7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%
7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%
2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%
Top News Decliners
2/6 Form 8-K LEMAITRE VASCULAR INC For: Feb 06 -19.5%
3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%
3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%
7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%
4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%
4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%
4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%
4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%
10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%
11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3